BELFB
Bel Fuse Inc /nj Information Technology Electronic Coils, Transformers & Other Inductors Russell 3000
$236.15Close
$134.24 – $332.9652-week range
Late-januaryNext report · estimated
Highlights
Cautions
- Not in an uptrend 3 of 8 trend conditions
- Far from its high 29% below its 52-week high
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
29%
1wk
up 18.4%
price change
1mo
down 3.2%
price change
12-month return
up 57%
market up 11% ·
its own up 44%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 26%
year on year
EPS growth
—
latest quarter
Sales growth
up 25%
latest quarter · +8 pts
ROE
up 19%
return on equity
Free cash margin
up 10%
$68.6M FCF
D/E
0.46
long-term debt / equity
Net debt / EBITDA
1.0×
Interest cover
—EBIT / interest
Piotroski tests
Repair signals
- Long-term debt down 31% ($0.3B → $0.2B)
- Gross margin 37.8% → 39.1%
- Revenue reaccelerating (-16% then +26%)
Trade setup
ATR%
5.2%
$12.17 a day · 2×ATR $211.81
RS
54 / 99
vs the universe
Trend
3 / 8
trend template
Relative volume
1.8×
vs 50-day average
Up/down volume
1.20
50 sessions
Implied move
—
no scheduled report
Trend template · 3 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: fails
- Price above the 50-day average: fails
- At least 30% above the 52-week low: passes
- Within 25% of the 52-week high: fails
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Material impairment The company disclosed a material impairment - an asset written down below the value the balance sheet had been carrying.
Last reported
Oct 28, 2026
Results reaction
Oct 28, 2026+5% vs market2 sessions after results
Financials
- Gross 39%
- Net 11%
- Free cash 10%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $465.8M | $543.5M | $654.2M | $639.8M | $534.8M | $675.5M |
| Gross margin | 26% | 25% | 28% | 34% | 38% | 39% |
| Operating income | $18.7M | $31.3M | $65.1M | $88.0M | $64.3M | $111.0M |
| Net income | $12.8M | $24.8M | $52.7M | $73.8M | $49.2M | $74.1M |
| Net margin | 3% | 5% | 8% | 12% | 9% | 11% |
| Free cash flow | $40.6M | -$4.8M | $31.4M | $96.2M | $60.0M | $68.6M |
| Free cash margin | 9% | -1% | 5% | 15% | 11% | 10% |
| Cash | $84.9M | $61.8M | $70.3M | $89.4M | $68.3M | $57.8M |
| Long-term debt | $110.3M | $112.5M | $95.0M | $60.0M | $287.5M | $197.5M |
| Shareholders' equity | $185.8M | $208.7M | $262.3M | $340.6M | $360.6M | $425.5M |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 4, 2026 | Quarterly ↗ | Jun 30, 2026 | 35d |
| May 5, 2026 | Quarterly ↗ | Mar 31, 2026 | 35d |
| Feb 24, 2026 | Annual ↗ | Dec 31, 2025 | 55d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Jul 31, 2025 | Quarterly ↗ | Jun 30, 2025 | 31d |
| May 1, 2025 | Quarterly ↗ | Mar 31, 2025 | 31d |
| Feb 28, 2025 | Annual ↗ | Dec 31, 2024 | 59d |
| Oct 29, 2024 | Quarterly ↗ | Sep 30, 2024 | 29d |
| Jul 31, 2024 | Quarterly ↗ | Jun 30, 2024 | 31d |
| Apr 30, 2024 | Quarterly ↗ | Mar 31, 2024 | 30d |
| Mar 11, 2024 | Annual ↗ | Dec 31, 2023 | 71d |
| Nov 3, 2023 | Quarterly ↗ | Sep 30, 2023 | 34d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 28, 2026 | Results ↗ |
| Jul 29, 2026 | Results ↗ |
| Jul 2, 2026 | Director or officer change ↗ |
| May 28, 2026 | Director or officer change · Shareholder vote ↗ |
| May 14, 2026 | Material agreement · Other events ↗ |
| May 12, 2026 | Other events ↗ |
| Apr 29, 2026 | Results ↗ |
| Apr 6, 2026 | Results · Director or officer change ↗ |
| Feb 17, 2026 | Results ↗ |
| Jan 15, 2026 | Director or officer change · Regulation FD · Other events ↗ |
| Dec 10, 2025 | Auditor change ↗ |
| Dec 3, 2025 | Impairment · Regulation FD ↗ |